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The aim of the present study was to evaluate the in vitro cytotoxic effects of zinc oxide nanoparticles (ZnONPs) with 
particle size of 40 and 50 nm against human hepatocellular carcinoma and human breast cancer cell lines. The effects of 
nanoparticles were analyzed after 24 hours of incubation using standard MTT assay. Incubation of ZnONPs with different cells 
produced a dose-dependent inhibition of cell growth. The IC50 values of ZnONPs for both prepared samples (40 and 50 nm) 
were comparable. It has been noticed that MCF-7 and MDA cells were more affected by the prepared 50 nm than the 40 nm 
ZnONPs. On the other hand, HepG2 cells showed inverse relation in terms of their response to the size of the prepared NPs. 
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Introduction 
Nanotechnology is considered to be one of the 
fastest growing technologies in the last two decades. It 
has been involved in various academic as well as 
industrial fields, including chemistry, biology, 
medicine and physics
1
. Nanotechnology is the field 
dealing particles having a general size in the nano-
range
2
. Nanomaterials have been widely appreciated 
for possessing characteristics, in terms of size and 
shape, which are uniquely different from their main 
constituting atoms
3
. These novel characteristics offered 
nanoparticles great application range in almost all 
industrial sectors. Bionanotechnology is the field that 
concerns with the application of nanoparticles in 
biological fields. It has proved to be an efficient and 
attractive field in many biotechnological processes
4
. 
Zinc oxide nanoparticles (ZnONPs) are prepared form 
zinc metal oxides, and they have large specific area and 
high surface energies
5
. Therefore, they found many 
interesting applications in solar cells, gas sensors, 
photpcatalysts, pharmaceutical drugs
6,7
. In the recent 
years, nanoparticles ((ZnONPs) have been investigated 
widely for their potential application as bioactive 
materials against many pathogenic microorganisms and 
cancer cell lines
4,8,9
.ZnONPs exhibited great selectivity 
towards cancer cells, and were able to avoid interfering 
with normal cell structure and metabolism
10
. 
Accordingly, they have been investigated in the 
treatments of many cancer diseases with the aim to 
overcome chemotherapeutic toxic side effects
11
. The 
aim of the current work was designed to evaluate the 
potential anticancer activities of chemically 
synthesized ZnONPs. The work was performed on two 
sizes of ZnONPs (40 and 50 nm). Cytotoxic activities 
were performed against different hepatocellular and 
breast cancer cell types. Also, the morphology of the 
affected cells was investigated microscopically.. 
 
Materials and methods 
 
Preparation of stock and working solutions 
The prepared ZnO nanoparticles (40 and 50 nm) 
were used to prepare a stock solution of 10 mg/mL in 
DMSO. Serial dilution with cultivation medium was 
used to prepare working nanoparticle solutions (0.0-
0.1 mg/mL).  
 
Cell cultivation and cytotoxic assay 
HepG2, human hepatocellular carcinoma; MCF-7 
and MDA-MB-231, human breast cancer cell lines 
were obtained from Sigma-Aldrich Chemical 
Company, USA, and were maintained in DMEM 
—————— 
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medium supplemented with 10% FBS and antibiotic 
solution. Cell cultivation and propagation was 
performed as per our developed protocol
12
. MTT 
standard cytotoxicity assay
13
 was used to assess 
different cytotoxic effects of ZnONPs. The assay 
protocol previously used in our work was followed
14,15
. 
Treated cells were examined with an inverted contrast 
microscope for possible morphological changes (Nikon 
Eclipse T500, Japan) at 10x magnification. 
 
Statistical analysis 
Experiments were repeated thrice, and results are 
presented as mean ± standard deviation (S.D).  
ANOVA (One Way Analysis of Variance) was used 
statistically analyzethe obtained results, and 
significantly different results were denoted at p≤0.05.  
 
Result and Discussion 
The cytotoxic effects of the prepared ZnO 
nanoparticles on different cell lines (HepG2, MCF-7 
and MDA) have been evaluated. Results illustrated  
in Figure 1 showed clearly that increasing the 
concentration of both prepared ZnO nanoparticles  
(40 and 50 nm) adversely decreased the viability of 
treated cell lines, with a highly significant effect 
(p0.001). Moreover, the highest concentration 
applied (1 mg/mL) resulted in the highest decrease in 
cell viability in all cell lines, where the viability 
recorded 14.30.99, 25.330.2.37 and 50.933.57 for 
MDA, HepG2 and MCF-7 cells, respectively, in case 
of ZnO nanoparticles with 40 nm diameter. On the 
other hand, the 50 nm ZnO nanoparticles showed 
more or less improved cytotoxic effects, where the 
highest effect obtained upon using 1 mg/mL resulted 
in viabilities of 12.760.51, 27.020.55 and 
46.951.95 for MDA, HepG2 and MCF-7 cells. 
Furthermore, the results obtained for MCF-7 cells 
treated with 40 nm of ZnO nanoparticles revealed that 
the effect on cell viability was not statistically 
 
 
 
Fig.1 — Effect of different concentrations of both 40 and 50 nm of prepared ZnO nanoparticles on the viability of different cell lines. 
Data are expressed as means  SD. 
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significantly changed upon treating the cells with 
concentrations ranging from 15.6 to 125 ug/mL. 
Additionally, MCF-7 cells were not also significantly 
affected when they were treated with 15.6 ug/mL of 
50 nm of ZnO nanoparticles. The results tabulated in 
Table (1) represent the obtained IC50 values calculated 
for different cell lines as affected by different 
concentrations of the prepared nanoparticles. Results 
showed that different cell lines differ also in their 
obtained IC50 values, which also agrees with the 
aforementioned results for the dose-response data. 
Additionally, IC50 values obtained for both prepared 
samples (40 and 50 nm) were comparable, although it 
can be seen that MDA and MCF-7 cells were more 
affected by the prepared 50 nm of ZnONPs than the 
40 nm NPs. On the other hand, HepG2 cells showed 
inverse relation in terms of their response to the size 
of the prepared NPs. Figures 2 and 3 showed 
morphological changes in MDA, HepG2 and MCF-7 
cells in response to different concentrations of ZnO 
nanoparticles. Increasing nanoparticle concentration 
resulted in a drastic change in the morphological 
characteristics of the tested cell lines, which was 
concentration dependent. Cells shrank and lost their 
adherence capacity to the surface of the cultivation 
plate. Furthermore, maximal applied concentration 
resulted in cell rounding and complete floating 
compared to control plates. The above mentioned 
results showed clearly that different cell lines greatly 
differed in their reaction towards prepared 
nanoparticles depending on cell types and 
nanoparticle size. These results are in accordance with 
those previously reported
16,17
. Various cell types differ 
in their response to bioactive molecules due to their 
intrinsic dissimilarities in membrane structural 
composition and organization. Additionally, 
morphological examination results agree with that 
reported
18-20
. Authors observed similar severe 
morphological changes in MCF-7, HepG-2 and Vero 
cells upon treatment as a result for cell death through 
autophagy mechanisms. The disruption of the cell 
membrane activity by direct contact between 
nanoparticles and cell membrane is also reported to be 
responsible for antifungal activity of ZnO 
nanoparticles. Binding nanoparticles to microbial cell 
membrane by direct or electrostatic forces 
affectsmembrane permeability and induces an 
oxidative stress status, thus preventing cell growth
21
. 
It was previously shown that the smaller the particle 
size, the greater will be the biological effect.In our 
current work, ZnO nanoparticles displayed 
remarkable anticancereffects. The inhibitory effect on 
cell viability suggests the generation of ROS to be the 
most likely mechanism. ZnO with its intrinsic defects 
(zinc vacancies) produced electron-hole pairs, which 
reacts with water producing H+ and OH− ions. These 
electrons converts dissolved oxygen into superoxide 
radical anions, which in turn react with H+ producing 
HO2• radicals. Those radicals are finally converted 
into hydrogen peroxide anions (HO2−), which then 
 
Table 1 — IC50 values obtained for different cell lines in response 
to ZnO nanoparticles 
Size 
IC50 (µg/mL) 
MDA MCF-7 HepG2 
40 nm 198.97 522.51 236.61 
50 nm 191.70 468.49 247.59 
 
 
 
 
Fig. 2 — Changes in cell line morphology as affected by ZnO 
nanoparticles (40 nm) after 24 h. Images are captured using 
inverted contrast microscope (Nikon Eclipse T500) at 20x 
magnification. 
 
 
 
Fig. 3 — Changes in cell line morphology as affected by ZnO 
nanoparticles (50 nm) after 24 h. Images are captured using 
inverted contrast microscope (Nikon Eclipse T500) at 20x 
magnification. 
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react with hydrogen ions and produce hydrogen 
peroxide. Hydrogen peroxides have the ability to 
penetrate and disrupt cell membranesthrough their 
oxidative stress effect
22
. 
 
Conclusion 
The current work aimed at investigating the 
anticancer activities of different sizes prepared 
ZnONPs (40 and 50 nm) against different cancer cell 
lines. Results revealed that both prepared nanoparticles 
affected cancer cells adversely depending on the 
applied concentration. Moreover, treated cells suffered 
from serious morphological changes due to 
nanoparticle exposure. ZnONPs possible affect cancer 
cells by enhancing ROS generation, and finally leading 
to cell death. Results suggest that ZnONPs can be 
effectively used to inhibit the growth and proliferation 
of different cancer cell types. 
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